Skip to Main Content

The ALS Association Evergreen Chapter

 

Read More About It
VA Increases Rating for Veterans with ALS
Veteran Salute

We are thrilled to report that the U.S. Department of Veterans Affairs published regulations that would increase from 30% to 100% the minimum disability rating automatically provided to all veterans with ALS who qualify for service connected benefits! The rating would be provided regardless of the progression of the disease or whether or not a veteran is totally disabled at the time of their evaluation.

Because the disability rating is used to calculate monthly compensation payments and eligibility for other benefits, this means that veterans with ALS will begin to receive a higher level of benefits much sooner than they otherwise would under the existing regulations, which provide only a 30% minimum rating. It also means that veterans no longer will be forced to have their condition continually re-evaluated in order to receive a higher level of benefits as the disease progresses.

This is a tremendous victory for our military heroes with ALS! The regulation will speed access to benefits, decrease the burden on veterans and their families and help them to receive the compensation and benefits they need when they need them.

The ALS Association has strongly supported this regulation, which initially was proposed by the VA in June 2010. We submitted comments to the VA endorsing the proposal and have worked with both the VA and Members of Congress to implement it as soon as possible. You can read The ALS Association's comments here.

The text of the regulation is available here and additional details can be found in the initial "proposed rule" here.

Effective Dates

The regulation takes effect on January 19, 2012. It applies to applications for benefits that:

  • Are received by VA on or after January 19, 2012;
  • Were received by VA before January 19, 2012 but have not been decided by a VA regional office as of that date;
  • Are appealed to the Board of Veterans' Appeals on or after January 19, 2012;
  • Were appealed to the Board before January 19, 2012 but have not been decided by the Board as of that date.

Increased Compensation
In addition to making it easier for veterans to receive a higher disability rating, the regulation increases the compensation immediately available to all veterans. Under the current rules, veterans qualify for a minimum of $389 per month in compensation if they are rated 30% disabled (the current minimum rating for ALS). Under the new regulation, they qualify for a minimum of $2,769 per month. Note that this is just the minimum level of compensation. Additional amounts are available based on a number of factors including whether or not a veteran is married or has children.

Special Monthly Compensation
The VA also will add language to the current regulations that recommend veterans with ALS be considered for special monthly compensation (SMC). SMC is available to veterans with significant disabilities (such as losing the use of a limb) and entitles them to the highest level of disability compensation, as much as $100,000 per year.

Additional information about VA's compensation rates is available on the VA website. Compensation Rates are here: http://www.vba.va.gov/bln/21/Rates/comp01.htm. Rates for Special Monthly Compensation are here: http://www.vba.va.gov/bln/21/Rates/comp02.htm.

Decreasing the Burden on Veterans
Currently, ALS carries a minimum rating of 30% disability. While veterans with ALS can be rated 100% and higher, those who are newly diagnosed or whose disease has not progressed significantly may receive a lower rating and therefore a lower amount in monthly compensation. As the disease progresses, they then must continuously be re-evaluated by the VA in order to receive the appropriate disability rating and appropriate level of compensation and benefits.

This process has created challenges for veterans and their families not only because it delays receipt of the highest level of benefits, but also because it requires veterans to repeatedly go through the reevaluation process, which can be time consuming and can include additional paperwork and travel for PALS to receive examinations by VA physicians. It also delays the awarding of benefits because the process the VA uses to provide a disability rating to a veteran can be the longest part of the claims process.

According to the regulation, "we determined that providing a 100-percent evaluation in all cases would obviate the need to reassess and reevaluate veterans with ALS repeatedly over a short period of time, as the condition worsens and inevitably and relentlessly progresses to total disability, and we proposed to increase the minimum evaluation for ALS to 100 percent."

If you have questions or would like assistance, please contact your Care Services Coordinator; 

King County Sonja Zimmer  Phone 425-6561650 or sonja@alsa-ec.org

North Sound & Alaska  –Mary Rebar  Phone:  360-733-5222 maryr@alsa-ec.org

South Sound – Anne Eichmeyer  Phone: 253-254-8909 Email anne@alsa-ec.org

Central WA & Montana Lisa Schoonover – Phone 509-834-0433 lisas@alsa-ec.org

Eastern WA  and Idaho  NaDean Watkins- Phone:  877-201-3610 nadeanw@alsa-ec.org

Download the PDF of this announcement

 

 

 

Read More About It


Frontotemporal Dementia and ALS

By Sonja Zimmer, Patient Services Director, The ALS Association Evergreen Chapter

The frontotemporal dementias (FTD) are a group of degenerative brain disorders that share many medical features. All result from progressive damage to cells in the anterior temporal and/or more frontal lobes of the brain. The disorders are also known as frontotemporal lobar degeneration (FTLD). The hallmark of FTD is a gradual, progressive decline in behavior and/or language. As the disease progresses, it becomes more difficult for people to plan or organize activities, behave appropriately in social or work settings, interact with others, and care for oneself, resulting in increasing dependency.

While estimates vary, it is now believed that approximately 20-30% of ALS patients have the signs and symptoms of frontotemporal dementia. Upwards of 50% of ALS patients have mild changes in their ability to concentrate and focus on multiple ideas and/or actions at one time, as well as make complex judgments, called “executive functioning”. It is important to know that the majority of ALS patients that have mild changes in behavior DO NOT have FTD

Difficulties with diagnosis – Is it FTD or Alzheimer’s disease?

Historically, physicians had a difficult time distinguishing FTD from Alzheimer’s disease, psychiatric problems or several other neurological disorders. Today, increased medical understanding and advanced brain imaging techniques help the physician to make an accurate diagnosis. FTD and Alzheimer disease (AD) are characterized by deterioration of the brain, and a gradual, progressive loss of brain function. Frontotemporal dementia however, is primarily a disease of behavior and language dysfunction, while the characteristic of Alzheimer Disease is loss of memory. FTD often begins earlier than Alzheimer’s disease, and affects areas in the brain that are more anterior or ‘forward’ than those affected by Alzheimer’s.

Damage to the brain’s frontal and temporal lobes affect complex thinking and reasoning abilities which can result in other symptoms commonly associated with FTD. Increased damage in “executive functions” affects a person’s ability to plan, organize and execute activities, while emotional changes impact relationships. Symptoms may include:

• Easily distracted and increasing difficulty staying on task mentally.

• Mental rigidity and inflexibility, insistence on having his or her own way, increasing difficulty adapting to new or changing circumstances.

• Planning and problem solving changes, abstract reasoning decreases. Examples of this would include difficulty coordinating the cooking of a meal, or making a shopping list and performing necessary errands.

• Poor financial judgment, impulsive spending or financial risk taking.

• Reduced initiative, lack of motivation, and an apparent loss of interest in previously enjoyed hobbies and social activities.

• Lack of insight into one’s behavior develops early; the patient does not recognize changes in his or her own behaviors and shows no concern for the effect of these behaviors on others, including loved ones.

• Mood changes that can be abrupt and frequent.

Behavioral Presentation

Behavioral changes are typically seen as changes in personality, emotional blunting or loss of empathy that result in increasingly inappropriate social behavior. People gradually become less involved in routine daily activities and withdraw emotionally from others. Unusual behaviors may include swearing, overeating or drinking, impulsivity, shoplifting, hypersexual behavior, and deterioration in personal hygiene habits.

Language Presentation

The language deficits experienced by FTD patients are distinguished by two presenting issues: problems with expression of language or severe naming difficulty, and problems with word meaning.

The Caregiver’s Approach

There are three strategies: plan for success; old memories are the strongest; and structure is important. Develop an approach to care giving that maximizes strengths minimizes frustration.

Evidence from caregivers and physicians indicate that having a planned structure is very helpful for FTD patients who have trouble with apathy and initiation. It allows them to remain more engaged because they don’t have to make decisions about what to do. People with dis-inhibited behavior tend to benefit from greater activity because problem behaviors are worse when people are bored. Know that FTD progression is continual and inevitable. The more managed and structured the day is, the more you may enjoy being together, and the more you can feel in charge as a caregiver.

Treatment

There is no cure for FTD, and in most cases its progression cannot be slowed. Although no medications have been proven effective for FTD, many clinicians look to the medications and treatment approaches used in other, similar disorders to develop a therapeutic approach.

The Four Lobes of the Brain


Read More About It

Swine Flu 101

 

The virus, Influenza A, currently causing human illness is a new type of swine flu, and is transmitted from person-to-person through the human respiratory system.  Symptoms can include fever, cough, sore throat, fatigue, lack of appetite, runny nose, nausea, vomiting and diarrhea.  There are currently no vaccines to prevent the swine flu, but there are medications to help treat the symptoms and help prevent serious flu complications.

Using the following precautions can help prevent the transmission of not only the Swine flu, but all influenza viruses:

 

Cover your nose and mouth with a tissue when coughing, sneezing

No tissue handy? Cough into your sleeve, not your hands Wash your hands thoroughly and often

 

   1. When you cough or sneeze, cover you nose and mouth with a tissue.
   2. Avoid touching your eyes, nose and mouth.
   3. Wash your hands with soap and water, or use alcohol-based hand cleaners.
   4. Try to avoid contact with sick people.
   5. If you get sick, stay home!

 

Some useful and/or informative links:

FIRST LOOK: Swine Flu Virus Revealed

SWINE FLU GUIDE: Your Source for Breaking News, Medical Facts and Practical Advice

 
   

 

 

 

 

 

 
Have you enrolled in the National ALS Registry?
 
  If you have, please enter your name and email in the fields below.

*

*

*

 

 

Date of Birth:

 

 


   Please leave this field empty

 

 

 

UW Communication Disorders Research
Can you help us?

University of Washington researchers in the Department of Rehabilitation Medicine and Department of Speech and Hearing Sciences are developing two new questionnaires about the life impact of communication disorders. In the future, these questionnaires should help doctors, speech pathologists and other healthcare providers better understand the impact of communication disorders on the lives of people who live with them. Information in these questionnaires should help healthcare providers and their clients make plans for treatment that will be as successful as possible. We have rough drafts of the questionnaires ready, but we need your feedback to help finish them.

In this stage of our project, we are asking participants to complete two questionnaires. The first questionnaire asks about a variety of everyday communication situations (for example: Letting someone know what you need at the store; or Talking to friends in a restaurant). For each question you are asked to rate how much your health condition interferes with participating in these communication situations. The second questionnaire asks you to rate your speech needs. By speech needs, we mean those things you want and need to do with your speech in day to day activities (talking loudly, talking for long periods of time, talking to unfamiliar people).

Participants in this study will be asked to:
1. Participate in a one-time session that lasts approximately 1 ? - 2 hours 
2. Complete both questionnaires (marking answers on paper forms)
3. Tell the researchers if there are any items on the questionnaires that are difficult to understand, confusing, or even inappropriate for particular cultures or backgrounds. Did we miss anything?
4. Answer more in-depth questions about some of the items. These questions include:
a. What does this question mean to you? What does it make you think of?
b. What made you rate your interference in this situation as you did?
c. Would there be another way to ask this question that would be better for you?

Sessions will take place at the University of Washington (UW Medical Center / Harborview Medical Center), or alternative locations can be arranged for your convenience. Participation is voluntary and is completely unrelated to your medical care. All identifying information will be kept confidential. You will receive $25.00 for taking part in this study.  Parking reimbursement is available as well.

You are eligible to participate if you:
Are an adult 18 years of age or older.
Have a communication disorder related to any medical condition such as stroke, head and neck cancer, head injury, Parkinson’s Disease, Multiple Sclerosis or other conditions.
 
Are you interested?
Please contact us at:

Carolyn Baylor, Ph.D.     
Hearing Sciences
Phone: 206-755-2247    
Email: cbaylor@u.washington.edu  

Tanya Eadie, Ph.D.
Department of Speech and Hearing Sciences
Phone: 206-616-2753
Email: teadie@u.washington.edu

(reminder: we cannot guarantee confidentiality of information via email)

 

 
 
 

 



ABOUT SSL CERTIFICATES

Evergreen Chapter Home | Luncheon Homepage | Volunteer Homepage

The ALS Association Evergreen Chapter
(866)-STOP-ALS - 19115 68th Avenue S #H-105 Kent, WA 98032


All content and works posted on this website are owned and copyrighted by The ALS Association. ©2011